0000899243-23-006922.txt : 20230303 0000899243-23-006922.hdr.sgml : 20230303 20230303151502 ACCESSION NUMBER: 0000899243-23-006922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Corvese Brian CENTRAL INDEX KEY: 0001393207 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40908 FILM NUMBER: 23703376 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC. STREET 2: 162 FIFTH AVENUE, SUITE 900 CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MiNK Therapeutics, Inc. CENTRAL INDEX KEY: 0001840229 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-994-8250 MAIL ADDRESS: STREET 1: 149 FIFTH AVENUE STREET 2: SUITE 500 CITY: NEW YORK STATE: NY ZIP: 10010 FORMER COMPANY: FORMER CONFORMED NAME: AgenTus Therapeutics, Inc. DATE OF NAME CHANGE: 20210112 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-01 0 0001840229 MiNK Therapeutics, Inc. INKT 0001393207 Corvese Brian 149 FIFTH AVENUE, SUITE 500 NEW YORK NY 10010 1 0 0 0 Common Stock 2023-03-01 4 A 0 8553 2.09 A 307348 D The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date. By: /s/ Christine Klaskin, Attorney-in-Fact 2023-03-03